サウスカロライナにおける過体重の臨床試験
サウスカロライナ内の拠点で、過体重に関する35件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Spartanburg Medical Research, Spartanburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Prisma Health-Ped Endo, Greenville
- Coastal Carolina Research Ctr, North Charleston
被験者募集中第3相
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Tribe Clinical Research, Greenville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Medical Uni of SC Charleston, Charleston
- Coastal Carolina Research Ctr, North Charleston
- Hillcrest Clinical Research, Simpsonville
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Medical University Of South Carolina, Charleston
- Hillcrest Clinical Research, Simpsonville
- Spartanburg Medical Research, Spartanburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - Mauldin, Mauldin
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Coastal Pediatric Associates, Charleston
- Medical University of South Carolina Children Hospital - PIN, Charleston
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Associates - Patewood, Greenville
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Accellacare - Mt Pleasant, Mt. Pleasant
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Trial Management Associates, Myrtle Beach
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Bogan Sleep Consultants, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Accellacare Charleston, Mt. Pleasant
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Tribe Clinical Research, LLC, Greenville
- Accellacare - Mt Pleasant, Mt. Pleasant
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Tribe Clinical Research, LLC, Greenville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Bluffton
- AURORA-1 Clinical Site, Clemson
- AURORA-1 Clinical Site, Columbia
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bluffton
- AURORA-2 Clinical Site, Clemson
- AURORA-2 Clinical Site, Columbia
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Coastal Carolina Research Center, North Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Trial Management Associates, Myrtle Beach
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Greer
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Spartanburg Medical Research, Spartanburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Bogan Sleep Consultants, LLC, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Tribe Clinical Research, LLC, Greenville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Columbia Dermatology & Aesthetics, Columbia
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Coastal Carolina Res Ctr, North Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07745504Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Spartanburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Tribe Clinical Research LLC Dba Mountain View Clinical Research, Greenville
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Mauldin
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Greer
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Coastal Carolina Research Ctr, North Charleston
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT07607587A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
- Monroe Biomedical Research, North Charleston
被験者募集中第2相
18歳〜60歳 · 全性別 · 2026/06/22更新 · NCT07570758Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer
- University of South Carolina, Columbia
被験者募集中健康なボランティア歓迎
3歳〜5歳 · 全性別 · 2026/06/11更新 · NCT07583459Pistachio Snacking and Metabolic Flexibility
- Public Health Research Center: Clinical Exercise Research Center, Columbia
被験者募集中健康なボランティア歓迎
25歳〜45歳 · 全性別 · 2026/01/14更新 · NCT07340125Optimal Digital Weight Loss Treatment for Rural Individuals
- University of South Carolina, Columbia
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2025/12/23更新 · NCT06105957Fueling Strong Hearts for a Strong South Carolina
- Pee Dee Research and Education Center, Florence
被験者募集中
45歳〜80歳 · 全性別 · 2025/08/26更新 · NCT07140952ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。